• Comfortable working with rodents and bacterial and mammalian cell cultures

• Experienced in the analysis of bulk RNA and DNA sequencing data

• Proficient in basic wet laboratory procedures including qPCR, ELISA, DNA and RNA extractions, and live cell imaging 

• Able to competently work with gas chromatography, high performance liquid chromatography, fluorescence detection, and mass spectrometry

• Comfortable delivering oral presentations 

• Proficient in Microsoft Office, GraphPad Prism, and Ingenuity Pathways Analysis

• Experienced in customer service 

Publications

• Mora LR, Bishop MG, Rodriguez KA, Redling DM, Fox R, Stephens KE. Degraded myelin is associated with cold hypersensitivity in paclitaxel-induced peripheral neuropathy. [preprint] bioRχiv, (2026). 

• Osborn LR, Bishop MG, Rodriguez KA, Redling DM, Duplechain EA, Stephens KE. A novel model of paclitaxel-induced peripheral neuropathy produces a clinically relevant phenotype in mice. Current Neuropharmacology (in press).

• Rodriguez KA, Bishop MG, Osborn LR, Redling D, Sikes JD, Porter C, Stephens KE. High-resolution metabolic profiling of the effects of early-life stress after peripheral nerve injury. The Journal of Pain, 44, 106270, (2026).

• Chandrashekar R, Mulakala BK, Venna G, Rearick JR, Onyekweli B, Gurang M, Ruebel M, Rajasundaram D, Lu LA, Dada-fox J, Zeledon JA, Talatala R, Rodriguez KA, Osborn LR, Bishop MG, Smithe B, Stephens KE, Lucas EA, Yeruva L. Maternal early life stress during lactation impacted skeletal health of offspring in a rat model.Calcified Tissue International, 116(1):79, (2025). 

• Barnette DA, Schleiff M A, Osborn LR, Flynn N, Matlock M, Swamidass SJ, and Miller GP. Dual mechanisms suppress meloxicam bioactivation relative to sudoxicam. Toxicology 440.152478 (2020). 

• Muller JE, Osborn LR, Traver JR, Hillesheim PC, Zeller M, and Mirjafari A. 2-(Octadecylsulfanyl)-1,3-thiazole. IUCrData 5.2 (2020).

• Crosby SV, Ahmed IY, Osborn LR, Wang Z, Schleiff MA, Fantegrossi WE, Nagar S, Prather PL, Boysen G, and Miller GP. Similar 5F-APINACA Metabolism between CD-1 Mouse and Human Liver Microsomes Involves Different P450 Cytochromes. Metabolites, 12(8), 773, (2022).

Published abstracts

• Osborn LR, Bishop MG, Rodriguez KA, Redling DM, Fox R, Stephens KE. Myelin degradation as a driver of persistent, exclusive cold hypersensitivity in a model of chemotherapy-induced peripheral neuropathy. The Journal of Pain, 41, (2026). 

• Osborn LR, Bishop MG, Rodriguez KA, Redling D, Stephens KE. Comprehensive behavioral assessment of neurotoxicity in a translational model of paclitaxel-induced peripheral neuropathy. The Toxicologist, a Supplement to Toxicological Sciences, Abstract #4598 (2025).

• Osborn LR, Bishop MG, Rodriguez KA, Stephens KE. Behavioral effects of repeated paclitaxel cycles on paclitaxel-induced peripheral neuropathy resolution. The Journal of Pain, 25(4), 9 (2024).  

International and national presentations

• Poster presentation at the United States Association for the Study of Pain Annual Scientific Meeting in Philadelphia, PA, 03/26

  • “Myelin degradation as a driver of persistent, exclusive cold hypersensitivity in a model of chemotherapy-induced peripheral neuropathy”

• Poster presentation at the Society of Toxicology Annual Meeting and ToxExp in Orlando, FL, 03/25

  • “Comprehensive behavioral assessment of neurotoxicity in a translational model of paclitaxel-induced peripheral neuropathy”

• Poster presentation at the International Association for the Study of Pain World Congress on Pain in Amsterdam, NL, 08/24

  • "Behavioral effects of repeated paclitaxel cycles on paclitaxel-induced peripheral neuropathy”

• Poster presentation at the United States Association for the Study of Pain Annual Scientific Meeting in Seattle, WA,  04/24

  • “Behavioral effects of repeated paclitaxel cycles on paclitaxel-induced peripheral neuropathy resolution” 

Regional and local presentations

• Oral presentation at the UAMS Winthrop P. Rockefeller Cancer Institute Research Symposium, Little Rock, AR, 05/26

  •  “Myelin degradation as a driver of cold hypersensitivity during chemotherapy-induced peripheral neuropathy” 

• Oral presentation at Society of Toxicology South Central Regional Chapter Fall Meeting at Louisiana State University Health Sciences, New Orleans, LA, 10/23

  • “Effects of repeated paclitaxel exposure on paclitaxel-induced peripheral neuropathy development” 

• Poster presentation for the Arkansas Biosciences Institute Research Symposium, Little Rock, AR, 10/23

  • “Effects of repeated paclitaxel exposure on paclitaxel-induced peripheral neuropathy development” 

• Oral presentation for the Department of Pharmacology and Toxicology at the University of Arkansas for Medical Sciences, Little Rock, AR

  • “Persistent cold hypersensitivity in a model of paclitaxel-induced peripheral neuropathy” 08/25                                                                                             

  • “Behavioral effects of repeated paclitaxel cycles on paclitaxel-induced peripheral neuropathy”, 09/24

  •  “Evaluating effects of repeated paclitaxel exposure on Paclitaxel-induced peripheral neuropathy”, 09/23

  • “Evaluating epigenetic changes in paclitaxel-induced peripheral neuropathy for therapeutic targeting”, 10/22

• Poster presentation for the UAMS Winthrop P. Rockefeller Cancer Institute Research Symposium, Little Rock, AR, 05/23

  • “Mouse model of paclitaxel-induced peripheral neuropathy” 

• Poster presentation at Arkansas IDeA Networks of Biomedical Research Excellence 2019 Conference at the University of Arkansas, Fayetteville, AR, 10/19

  • “Meloxicam Detoxification Pathway Decreases Toxicity  Relative to Analog, Sudoxicam”                               

• Poster presentation at Society of Toxicology South Central Regional Chapter Fall Meeting at Louisiana State University Health Sciences, Shreveport, LA, 10/19

• o   “Meloxicam Detoxification Pathway Decreases Toxicity  Relative to Analog, Sudoxicam”                                           

• Oral presentation at Central Arkansas Undergraduate Research Symposium at University of Arkansas for Medical Sciences, Little Rock, AR, 07/19

  • “Meloxicam Detoxification Pathway Decreases Toxicity  Relative to Analog, Sudoxicam”                                                                                 

• Oral presentation at the Midsummer Symposium for the Department of Biochemistry and Molecular Biology at the University of Arkansas for Medical Sciences, Little Rock, AR  06/19

  •   “Meloxicam Detoxification Pathway Decreases Toxicity  Relative to Analog, Sudoxicam”